Cell-Free and Concentrated Ascites Reinfusion Therapy
Cell-free and concentrated ascites reinfusion therapy (CART) is used for ascites that is refractory to diuretic therapy. CART can increase oncotic pressure and reduce symptoms.
Serious adverse events are rare, but low-grade body temperature elevation can occur.
KeywordsHepatic Encephalopathy Transjugular Intrahepatic Portosystemic Shunt Ascites Fluid Disseminate Intravascular Coagulation Check Valve
- 1.Asahi Kasei Medical (2012) Package insert of ascites filter AHF-MO, Tokyo (in Japanese)Google Scholar
- 2.Takamatsu S et al (2003) The present state of cell-free and concentrated ascites reinfusion therapy (CART) for refractory ascites: focusing on the clinical factors affecting fever as an adverse effect of CART. Kan-Tan-Sui 46(5):663–669 (in Japanese)Google Scholar
- 3.Japanese CART Study Group, Matsusaki K et al (2011) Novel cell-free and concentrated ascites reinfusion therapy (KM-CART) for refractory ascites associated with cancerous peritonitis: its effect and future perspectives. Int J Clin Oncol 16(4):395–400Google Scholar
- 5.Ito T et al (2013) Single center experience of cell-free and concentrated ascites reinfusion therapy in malignancy related ascites. Ther Apher Dial (in press)Google Scholar
- 6.Japan Society of Hepatology. Management of Decompensated Liver Cirrhosis (2006) Guideline for the treatment of chronic hepatitis 2006. Bunkodo, Tokyo (in Japanese)Google Scholar